2.63

20.64% 0.45

Alaunos Therapeutics Inc (TCRT)

Overview News Price History Financials Discussions Forecast Stock Split

Alaunos Therapeutics Inc stock is traded at $2.63, with a volume of 31.82M. It is up +20.64% in the last 24 hours and up +105.47% over the past month. Alaunos Therapeutics Inc is a preclinical-stage biopharmaceutical company focused on the development of novel, orally administered small-molecule therapeutics for obesity and related metabolic disorders, such as metabolic dysfunction-associated steatotic liver disease (MASLD, a type of fatty liver disease). The program aims to develop a differentiated, non-hormonal, non-incretin approach, unlike hormone-based treatments like GLP-1 drugs. It has a single reportable and operating segment related to biopharmaceutical research and development.

Previous Close:

$2.18

Open:

$2.81

24h Volume:

31.82M

Relative Volume:

0.84

Market Cap:

$6.68M

Revenue:

$3,000

Net Income/Loss:

$-4.11M

P/E Ratio:

-1.2127

EPS:

-2.1688

Net Cash Flow:

$-3.23M

1W Performance:

+234.69%

1M Performance:

+105.47%

6M Performance:

-7.07%

1Y Performance:

-15.16%

1-Day Range:

$2.31

$2.99

1-Week Range:

$0.77

$4.40

52-Week Range:

$0.719

$4.50

Alaunos Therapeutics Inc Stock (TCRT) Company Profile

Name

Alaunos Therapeutics Inc

Sector

Healthcare (1052)

Industry

Biotechnology (594)

Phone

(346) 355-4099

Address

501 E LAS OLAS BLVD, FORT LAUDERDALE

Employee

Twitter

Next Earnings Date

2026-11-13

Latest SEC Filings

TCRT's Discussions on Twitter

Compare TCRT vs VRTX, MRNA, REGN, ARGX, ONC

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
TCRT Alaunos Therapeutics Inc	2.63	6.68M	3,000	-4.11M	-3.23M	-2.1688
VRTX Vertex Pharmaceuticals Inc	499.74	126.66B	12.34B	4.34B	3.71B	16.87
MRNA Moderna Inc	218.01	87.04B	2.23B	-3.19B	-1.60B	-8.1462
REGN Regeneron Pharmaceuticals Inc	790.74	81.41B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	819.14	51.51B	4.16B	1.29B	734.26M	19.58
ONC Beone Medicines Ltd Adr	369.06	41.75B	5.76B	514.49M	1.10B	4.4813

Alaunos Therapeutics Inc Stock (TCRT) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Oct-04-22	Resumed	Wells Fargo	Overweight

Alaunos Therapeutics Inc Stock (TCRT) Latest News

Oct 08, 2026

Alaunos Therapeutics (TCRT) director Jaime Vieser receives 22,669 shares in lieu of board fees. - Stock Titan

Oct 08, 2026

Board fees are paid in 20,990 shares to Alaunos Therapeutics (TCRT) director Michael Allen Jerman. - Stock Titan

Oct 08, 2026

Sep 24, 2026

Alaunos Therapeutics Inc (NASDAQ: TCRT) Share Price, TCRT Stock News, TCRT Share Price & Updates - kalkine.ca

Sep 24, 2026

Sep 23, 2026

Alaunos Therapeutics Announces New Registered Direct Offering - The Globe and Mail

Sep 23, 2026

Sep 22, 2026

Alaunos Therapeutics Announces New Registered Direct Offering - TipRanks

Sep 22, 2026

Sep 18, 2026

Alaunos Therapeutics prices registered direct offering to raise ~$1.12 million - TradingView

Sep 18, 2026

Alaunos Therapeutics raises $1.12M in registered direct offering - Investing.com

Sep 18, 2026

Alaunos Therapeutics, Inc. Announces Pricing of Registered Direct Offering priced at-the-market under Nasdaq rules - manilatimes.net

Sep 18, 2026

TCRT Stock Pops On Volatile Spike As Traders Circle - StocksToTrade

Sep 18, 2026

TCRT Stock Spikes On Heavy Volume As Traders Hunt Volatility - timothysykes.com

Sep 18, 2026

Stay updated with the stocks that are on the move in today's pre-market session. - ChartMill

Sep 18, 2026

TCRT Stock Sees Volatile Spike As Traders Target Momentum - timothysykes.com

Sep 18, 2026

Sep 10, 2026

Alaunos Therapeutics (TCRT) Holds Firm at $1.56 as Buyers Defend the Lower RangeMoving Average Crossovers - siam.in

Sep 10, 2026

Sep 09, 2026

Alaunos Therapeutics (TCRT) Slips 1.89% to $1.56 as Small-Cap Biotech Holds Above Key SupportMcClellan Oscillator - siam.in

Sep 09, 2026

Alaunos Therapeutics (TCRT) Slips 1.89% to $1.56 as Small-Cap Biotech Holds Above Key SupportPrice Target - careplusvn.com

Sep 09, 2026

Alaunos Therapeutics (TCRT) Slips 1.89% to $1.56 as Small-Cap Biotech Holds Above Key SupportSentiment Shift - dars.gov.et

Sep 09, 2026

Aug 23, 2026

Alaunos (TCRT) Latest: Moves 1.13% Lower to $1.76 on the Day; Price Setup: the Supplied Trading Band Runs From $1.67 to $1.85 on the DayCall Resistance - vinanet.vn

Aug 23, 2026

Alaunos (TCRT) Latest: Moves 1.13% Lower to $1.76 on the Day; Price Setup: the Supplied Trading Band Runs From $1.67 to $1.85 on the DayIV Crush Alert - dars.gov.et

Aug 23, 2026

Aug 20, 2026

Alaunos (TCRT) Results Versus Estimates: Profit Per Share Falls Below Its Benchmark in the Available Record; Market Move: The Stock Closes Near Unchanged in the Latest SessionAnnual Report - vinanet.vn

Aug 20, 2026

Aug 19, 2026

Alaunos (TCRT) EPS and Revenue: EPS Does Not Reach the Reported Estimate; Price Reaction: The Session Ends Near the Prior LevelAnalyst Coverage Count - vinanet.vn

Aug 19, 2026

Aug 14, 2026

Ziopharm: Q2 Earnings Snapshot - KTVB

Aug 14, 2026

Alaunos Therapeutics, Inc. Q2 2026: Revenue $0K, Net loss $988K, EPS $(0.41) — 10-Q Summary - TradingView

Aug 14, 2026

Alaunos Therapeutics (TCRT) warns on cash runway, Nasdaq compliance and losses - Stock Titan

Aug 14, 2026

Aug 11, 2026

Alaunos Therapeutics (TCRT) CEO granted 4,363 shares in lieu of cash salary - Stock Titan

Aug 11, 2026

Aug 08, 2026

Alaunos Therapeutics (TCRT) Holds Flat at $1.99 as Key Support and Resistance Levels Come into FocusTWAP Entry - dars.gov.et

Aug 08, 2026

Aug 06, 2026

Enterprise value to EBITDA forward of Alaunos Therapeutics, Inc. – NASDAQ:TCRT - TradingView

Aug 06, 2026

Jul 31, 2026